About Us

Novartis Ophthalmics, a division of Novartis Pharmaceuticals Corporation, is a leader in discovering, developing, and delivering innovative medications that treat wet age-related macular degeneration, ocular allergies, dry eye, inflammation, and other diseases of the eye.

Our vision is to deliver the next generation of breakthrough ophthalmic products to physicians and their patients. Because it is a part of one of the largest global pharmaceutical corporations, Novartis Ophthalmics has access to immense resources and extensive scientific expertise, especially in the area of research and development.

Our Mission
We at Novartis Ophthalmics believe that there are few gifts more precious than sight. . . .

Awards
Novartis Ophthalmics has received several prestigious awards for innovation. . . .

History
Novartis AG was created in 1996, when the merger of Ciba-Geigy and Sandoz was approved. . . .